ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Fufang Zhenzhu Tiaozhi capsule ameliorates hyperuricemic nephropathy by inhibition of PI3K/AKT/NF-?B pathway

Li, Ming -Hui; Guan, Jin; Chen, Zhe; Mo, Ju-Xian; Wu, Kai-Reng; Hu, Xu-Guang; Lan, Tian*; Guo, Jiao广东药学院
Journal of Ethnopharmacology2022-11-15DOI: 10.1016/j.jep.2022.115644
8被引10阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Excessive serum uric acid (SUA) causes hyperuricemic nephropathy (HN), characterized by inflammatory infiltration and tubulointerstitial fibrosis. Most recently, we demonstrated that Fufang Zhenzhu Tiaozhi (FTZ) capsule attenuated diabetic nephropathy through inhibition of renal inflammation and fibrosis. However, whether FTZ ameliorates HN is still unclear. Aim of the study: To determine the protective roles and mechanism of FTZ in mouse renal injury and fibrosis under hyperuricemic condition. Materials and methods: HN mice, induced by potassium oxonate and hypoxanthine, were administrated with 600 and 1200 mg/kg FTZ (intragastrically) daily for three weeks. SUA levels, renal functions and histological changes were analyzed. Western blotting, quantitative real-time PCR (q-PCR) and RNA sequencing were used to identify the roles and underlying mechanism of FTZ in HN mice. Results: We demonstrated that FTZ treatment mitigated renal injury in mice, as evidenced by the decrease in SUA, serum creatinine (SCr) and cystatin C (Cys C) levels, as well as improved renal histology. FTZ markedly attenuates inflammasome activation, collagen deposition and the imbalance of uric acid transporters. RNA-sequencing revealed a key mechanism involved in the protective effects on HN mice was related to PI3K/AKT/NF-& UKappa;B pathway. Western blot also confirmed that FTZ diminished the phosphorylation of AKT and p65 in HN mice. Conclusions: FTZ prevents renal injury, inflammation and fibrosis in HN mice via promoting uric acid excretion and inhibiting PI3K/AKT/NF-kappa B signaling pathway.

学科与关键词

关键词
FTZHyperuricemic nephropathyInflammationFibrosisPI3KNF-?BUric acid transporters
相关
加载中…
  • The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease
    Yang, Yi-Qi; Tan, Hai-Bo; Zhang, Xiao-Yu; Zhang, Yu-Zhen; Lin, Quan-You; Huang, Min-Yi; Lin, Zi-Yang; Mo, Jia-Zhi; Zhang, Yue; Lan, Tian; Bei, Wei-Jian; Guo, Jiao*Journal of Ethnopharmacology, 2022, 292: 115165.被引 14
  • Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway
    Li, Yongmei; Zhao, Zean; Luo, Jian; Jiang, Yanqing; Li, Lu; Chen, Yanyu; Zhang, Leqi; Huang, Qinghua; Cao, Ying; Zhou, Pingzheng; Wu, Ting; Pang, Jianxin*PHYTOMEDICINE, 2021, 87: 153585.被引 30
  • Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway
    Liu, Yanlu; Gong, Shiting; Li, Kejian; Wu, Gong; Zheng, Xiaohong; Zheng, Jingna; Lu, Xiaowei; Zhang, Luyao; Li, Jincan; Su, Ziren; Liu, Yuhong; Xie, Jianhui; Chen, Jiannan*; Li, Yucui*Biomedicine and Pharmacotherapy, 2022, 156: 113941.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2022-11-15
卷期
第 298 卷
页码
115644
DOI
10.1016/j.jep.2022.115644
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81830113, 81870420, 82070590]; Major Basic and Applied Basic Research Projects in Guangdong Province of China [2019B030302005]; National Key R & D Plan of China ? [2018YFC1704200]

作者

  • L

    Li, Ming -Hui (第一作者)

    guangdong pharmaceut univ

  • G

    Guan, Jin

    guangdong pharmaceut univ

查看全部 8 位作者收起作者
  • C

    Chen, Zhe

    guangdong pharmaceut univ

  • M

    Mo, Ju-Xian

    guangdong pharmaceut univ

  • W

    Wu, Kai-Reng

    guangdong pharmaceut univ

  • H

    Hu, Xu-Guang

    guangdong pharmaceut univ

  • L

    Lan, Tian (通讯)

    guangdong pharmaceut univ

  • G

    Guo, Jiao

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417